UP!

News

BG Medicine, Inc. -11.11% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2016 2016-05-16 Future report Set alerts
Q4 2015 2016-02-16 0.00 0.00
Q3 2015 2015-11-16 0.00 -0.27
Q2 2015 2015-08-14 0.00 -0.24
Q1 2015 2015-05-14 0.00 -0.16
Q4 2014 2015-03-31 0.00 -0.16
Q3 2014 2014-11-13 0.00 -0.28
Q2 2014 2014-08-14 0.00 -0.24
Q1 2014 2014-05-14 0.00 -0.32
Q4 2013 2014-03-20 0.00 -0.24

Ratings

4766-03-31
2014-11-13 Downgrade Ladenburg Thalmann Buy to Neutral
2014-03-21 Boost Price Target Ladenburg Thalmann $1.50 to $2.40
2013-08-08 Reiterated Ladenburg Thalmann Buy $7 to $1.50
2012-11-14 Reiterated Mizuho Buy $6 to $4
2012-08-31 Initiated Mizuho Buy $6
2011-12-21 Initiated Ladenburg Thalmann Buy $8.25
2011-03-16 Initiated Robert W. Baird Outperform $12
1970-01-01
4766-03-31
2014-11-13 Downgrade Ladenburg Thalmann Buy to Neutral
2014-03-21 Boost Price Target Ladenburg Thalmann $1.50 to $2.40
2013-08-08 Reiterated Ladenburg Thalmann Buy $7 to $1.50
2012-11-14 Reiterated Mizuho Buy $6 to $4

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In BGMD 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
AGTC Partners, L.P. 6.83%  (2351447) BGMD /
van der Meer Pieter 4.75%  (1635432) BGMD /
PAPADOPOULOS STELIOS 3.45%  (1187713) BGMD / BIIB / EXEL / RGLS /
Bancel Stephane Executive Chairman 0.36%  (123167) BGMD /
Muntendam Pieter President, CEO 0.23%  (78483) BGMD /
SOHMER PAUL R President & CEO 0.15%  (53161) BGMD /
Adourian Aram S. VP, Scientific Affairs 0.12%  (40036) BGMD /
HALL STEPHEN P EVP & Chief Financial Officer 0.09%  (31034) BGMD / STML /
Posner Brian S 0.06%  (20000) ACGL / BGMD / BIIB / SCD /
Bouvier Eric President, CEO 0.03%  (10000) BGMD /

Comments